Welbusol Inhalation 1.25mg Solution

Introduction

Welbusol Inhalation is a prescription medication that contains the active ingredient Levosalbutamol. It is available in the form of an inhalation solution and is commonly prescribed under this brand name. Levosalbutamol is a bronchodilator that helps to relax the muscles in the airways, making it easier to breathe.

Uses

Welbusol Inhalation is primarily prescribed for the treatment of asthma and other conditions that cause narrowing of the airways, such as chronic obstructive pulmonary disease (COPD). It is used to relieve symptoms such as wheezing, shortness of breath, and coughing.

Dosage and Administration

The dosage of Welbusol Inhalation may vary depending on the severity of your condition and your individual response to the medication. Follow the instructions provided by your healthcare professional. Typically, the recommended dose for adults and children above 12 years of age is 2.5 mg to 5 mg of Levosalbutamol inhaled through a nebulizer or a metered-dose inhaler, every 4 to 6 hours. However, your healthcare professional may adjust the dosage as per your specific needs.

Mechanism of Action

Levosalbutamol, the active ingredient in Welbusol Inhalation, works by selectively targeting and stimulating specific receptors called beta-2 adrenergic receptors in the smooth muscles of the airways. This stimulation results in the relaxation of the muscles, leading to the dilation of the airways and improved airflow into the lungs. By opening up the airways, Levosalbutamol helps to alleviate the symptoms of conditions such as asthma and COPD.

Side Effects

Common side effects may include headache, tremor, palpitations, and nervousness. These side effects are usually mild and go away on their own. However, if you experience any serious side effects such as chest pain, irregular heartbeat, or difficulty breathing, seek immediate medical attention.

Drug Interactions

Welbusol Inhalation may interact with certain medications, potentially affecting their effectiveness or increasing the risk of side effects. Inform your healthcare professional about all the medications you are currently taking, including prescription drugs, over-the-counter medications, and herbal supplements. Some common medications that may interact with Welbusol Inhalation include beta-blockers, diuretics, and monoamine oxidase inhibitors (MAOIs). Your healthcare professional will closely monitor and adjust your medication regimen to minimize any potential interactions.

Precautions

Before using Welbusol Inhalation, inform your healthcare professional about any existing medical conditions, allergies, or medications you are taking. This medication may not be suitable for individuals with certain conditions such as heart disease, high blood pressure, or diabetes. Avoid using Welbusol Inhalation if you are allergic to Levosalbutamol or any other ingredients in the medication. Additionally, avoid using Welbusol Inhalation with other medications that contain beta-2 adrenergic agonists, as this may increase the risk of side effects.

Storage

Welbusol Inhalation should be stored at room temperature, away from direct sunlight and moisture. Keep the medication out of the reach of children and pets. Do not use the medication if it has expired or if the solution has changed color or become cloudy. If you have any unused or expired medication, consult your healthcare professional or pharmacist for proper disposal instructions.

Patient Tips

• Follow the dosage instructions provided by your healthcare professional and do not exceed the recommended dose.
• If you are using a metered-dose inhaler, make sure to shake it well before each use and follow the proper technique for inhalation.
• Keep track of your medication supply and refill it before it runs out to ensure uninterrupted treatment.
• If you experience any new or worsening symptoms while using Welbusol Inhalation, contact your healthcare professional.
• attend regular check-ups with your healthcare professional to monitor your condition and adjust your treatment plan if needed.

Please note that this description, as well as the other content on our website is for educational purposes only. We do not provide medical advice. For specific medical advices, diagnoses and treatment options you should consult with your doctor.

References

• Levosalbutamol (International database) (Drugs.com) [Accessed 27 Jun. 2024] (online) Available at:
• Ormrod D, Spencer CM. Levosalbutamol. BioDrugs. 1999 Jun;11(6):431-8. doi: 10.2165/00063030-199911060-00007. [Accessed 29 Jun. 2024] Available at:
• Ipratropium Bromide (International database) (Drugs.com) [Accessed 8 Jun. 2024] (online) Available at:
• Gupta MK, Singh M. Evidence based review on levosalbutamol. Indian J Pediatr. 2007 Feb;74(2):161-7. doi: 10.1007/s12098-007-0010-5. [Accessed 29 Jun. 2024] Available at: